Objectives:

1. Improve utilization & adherence to GL recommended therapies in CV prevention.

2. Improve identification and treatment of FH.

3. Improve use of partnerships and registries for care.

 

Session date: 
Friday, December 7, 2018 - 12:00pm to 1:00pm
Speaker Name: 
Laurence S. Sperling, MD, FACC, FAHA, FACP, FASPC
Location: 
UCMC
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.